206 related articles for article (PubMed ID: 24486299)
1. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease.
Yang W; Chauhan A; Mehta S; Mehta P; Gu F; Chauhan V
Life Sci; 2014 Mar; 99(1-2):31-6. PubMed ID: 24486299
[TBL] [Abstract][Full Text] [Related]
2. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
[TBL] [Abstract][Full Text] [Related]
3. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
[TBL] [Abstract][Full Text] [Related]
4. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
5. Peripheral transgene expression of plasma gelsolin reduces amyloid in transgenic mouse models of Alzheimer's disease.
Hirko AC; Meyer EM; King MA; Hughes JA
Mol Ther; 2007 Sep; 15(9):1623-9. PubMed ID: 17609655
[TBL] [Abstract][Full Text] [Related]
6. Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects.
Ji L; Chauhan V; Mehta P; Wegiel J; Mehta S; Chauhan A
J Alzheimers Dis; 2010; 22(2):609-17. PubMed ID: 20847428
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic implications of gelsolin in Alzheimer's disease.
Ji L; Zhao X; Hua Z
J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
[TBL] [Abstract][Full Text] [Related]
8. Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease.
Chauhan V; Ji L; Chauhan A
Biogerontology; 2008 Dec; 9(6):381-9. PubMed ID: 18704746
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
[TBL] [Abstract][Full Text] [Related]
10. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
11. beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology.
Vehmas AK; Borchelt DR; Price DL; McCarthy D; Wills-Karp M; Peper MJ; Rudow G; Luyinbazi J; Siew LT; Troncoso JC
DNA Cell Biol; 2001 Nov; 20(11):713-21. PubMed ID: 11788049
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
Fabbro S; Schaller K; Seeds NW
J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
[TBL] [Abstract][Full Text] [Related]
13. Impairments of long-term depression induction and motor coordination precede Aβ accumulation in the cerebellum of APPswe/PS1dE9 double transgenic mice.
Kuwabara Y; Ishizeki M; Watamura N; Toba J; Yoshii A; Inoue T; Ohshima T
J Neurochem; 2014 Aug; 130(3):432-43. PubMed ID: 24684630
[TBL] [Abstract][Full Text] [Related]
14. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
[TBL] [Abstract][Full Text] [Related]
15. Trichostatin A ameliorates Alzheimer's disease-related pathology and cognitive deficits by increasing albumin expression and Aβ clearance in APP/PS1 mice.
Su Q; Li T; He PF; Lu XC; Yu Q; Gao QC; Wang ZJ; Wu MN; Yang D; Qi JS
Alzheimers Res Ther; 2021 Jan; 13(1):7. PubMed ID: 33397436
[TBL] [Abstract][Full Text] [Related]
16. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo JS; Jung EY; Kim JH; Lyu YS; Han PL; Kang HW
J Ethnopharmacol; 2010 Aug; 130(3):578-85. PubMed ID: 20669372
[TBL] [Abstract][Full Text] [Related]
17. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
[TBL] [Abstract][Full Text] [Related]
18. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
[TBL] [Abstract][Full Text] [Related]
19. Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.
Güntert A; Campbell J; Saleem M; O'Brien DP; Thompson AJ; Byers HL; Ward MA; Lovestone S
J Alzheimers Dis; 2010; 21(2):585-96. PubMed ID: 20571216
[TBL] [Abstract][Full Text] [Related]
20. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
Dragicevic N; Bradshaw PC; Mamcarz M; Lin X; Wang L; Cao C; Arendash GW
Neuroscience; 2011 Jun; 185():135-49. PubMed ID: 21514369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
